AmpliPhi Biosciences (APHB) Reports Q3 Loss of $0.09

AmpliPhi Biosciences (NYSE: APHB) reported Q3 EPS of ($0.09), versus ($0.30) reported last year. Revenue for the quarter came in at $38 thousand versus the consensus estimate of $29 thousand.

For earnings history and earnings-related data on AmpliPhi Biosciences (APHB) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c